CALIFORNIA VIOXX LAWYER - California Vioxx Attorney

Vioxx
Vioxx (Rofecoxib) was approved by the US Food and Drug Administration in 1999 for the treatment of osteoarthritis, menstrual pain and for the management of acute pain in adults. Vioxx is a non-steroidal anti-inflammatory drug (NSAID), and is in a class of drugs commonly referred to as a "Cox-2 inhibitor". Health concerns have been raised in recent months regarding the use of Vioxx. An article published in June, 2001 in the medical journal The Lancet raised concerns over the possible impact on kidney health, and an article published in August, 2001 in the medical journal JAMA (Journal of the American Medical Association) raised concerns over the possible impact on cadiovascualar health. In September, 2001 the American Heart Association, the National Stroke Association and the Arthritis Foundation asked Vioxx' manufacturer (Merck & Co.) to test whether Vioxx increase the risk of heart attack and stroke. In addition, the US Food and Drug Administration sent Vioxx' manufacturer (Merck & Co.) a "Warning Letter" on September 17, 2001, which, among its contents, required Merck to cease certain promotional activities for Vioxx.

CALIFORNIA CELEBREX LAWYER - California Celebrex Attorney

Celebrex (Celecoxib) was approved by the US Food and Drug Administration (FDA) on December 31, 1998 for the treatment of rheumatoid arthritis and osteo-arthritis. Also, on December 23, 1999 the FDA approved Celebrex as a drug treatment aimed at reducing the number of intestinal polyps in patients with a rare genetic disorder called familial adenomatous polyposis (FAP). Celebrex is a non-steroidal anti-inflammatory drug (NSAID), and is in a class of drugs commonly referred to as a "Cox-2 inhibitor". Health concerns have been raised in recent months regarding the use of Celebrex. An article published in August, 2001 in the medical journal JAMA (Journal of the American Medical Association) raised concerns over the possible impact on cadiovascualar health. In September, 2001 the American Heart Association, the National Stroke Association and the Arthritis Foundation asked Celebrex' manufacturer (Pharmacia Corp.) to test whether Celebrex increases the risk of heart attack and stroke. In addition, the US Food and Drug Administration sent Celebrex' manufacturer (Pharmacia Corp.) a "Warning Letter" on February 1, 2001, which, among its contents, required Pharmacia Corp. to cease certain promotional activities for Celebrex.

Do you have a case involving a dangerous drug? Fill out our online form and have an attorney contact you about your case.

Please click here to go to our online form.

If you or a loved one has been injured due to a dangerous drug
it is important to protect your legal rights. Time is important,
consult with an experienced california vioxx attorney today!

Call California Vioxx Lawyer Toll-Free
1-866-494-6587

Free California Dangerous Drug Case Evaluation